DreamCIS, Inc. (KOSDAQ:223250)
5,100.00
+60.00 (1.19%)
At close: Apr 28, 2026
DreamCIS Revenue
In the year 2025, DreamCIS had annual revenue of 66.63B KRW with 13.60% growth. DreamCIS had revenue of 19.34B in the quarter ending December 31, 2025, with 30.91% growth.
Revenue
66.63B
Revenue Growth
+13.60%
P/S Ratio
1.88
Revenue / Employee
170.85M
Employees
390
Market Cap
125.46B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HLB bioStep | 74.05B |
| P&K Skin Research Center | 22.78B |
| WOOJUNG BIO | 37.59B |
| DT&CRO CO. | 47.75B |
| C&R Research | 64.98B |
| SLS BIO | 3.98B |
| Penetrium Bioscience | 9.74B |
| BioInfra | 23.15B |